Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingWages, Salaries and Other
Ratios

Marimed (MRMD) Non-Current Receivables (2016 - 2025)

Historic Non-Current Receivables for Marimed (MRMD) over the last 11 years, with Q2 2025 value amounting to $827000.0.

  • Marimed's Non-Current Receivables rose 159.71% to $827000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $827000.0, marking a year-over-year increase of 159.71%. This contributed to the annual value of $840000.0 for FY2024, which is 319.41% up from last year.
  • As of Q2 2025, Marimed's Non-Current Receivables stood at $827000.0, which was up 159.71% from $814000.0 recorded in Q1 2025.
  • Over the past 5 years, Marimed's Non-Current Receivables peaked at $9.2 million during Q3 2022, and registered a low of $814000.0 during Q3 2023.
  • Its 5-year average for Non-Current Receivables is $4.0 million, with a median of $1.8 million in 2021.
  • In the last 5 years, Marimed's Non-Current Receivables surged by 42408.65% in 2022 and then plummeted by 9111.35% in 2023.
  • Marimed's Non-Current Receivables (Quarter) stood at $9.0 million in 2021, then decreased by 16.91% to $7.5 million in 2022, then crashed by 89.1% to $814000.0 in 2023, then increased by 3.19% to $840000.0 in 2024, then fell by 1.55% to $827000.0 in 2025.
  • Its last three reported values are $827000.0 in Q2 2025, $814000.0 for Q1 2025, and $840000.0 during Q4 2024.